ARTICLE | Company News

NewBridge Pharmaceuticals, Orexo sales and marketing update

September 27, 2010 7:00 AM UTC

Orexo granted NewBridge exclusive rights to commercialize Abstral fentanyl in 64 countries in the Middle East and Africa, excluding Israel. NewBridge is responsible for registration in the territories. Orexo will receive an upfront payment and is eligible for milestones, plus royalties. Further financial terms were not disclosed. ...